Related Experiment Videos
[Bilateralization of breast cancer]
Bulletin Du Cancer
|January 1, 1986
Summary
Advanced breast cancer stages and inflammatory signs increase bilateralization risk. Early-stage T1 tumors may lead to a second cancer over time, justifying continued follow-up.
Area of Science:
- Oncology
- Cancer Research
- Epidemiology
Context:
- Bilateral breast cancer risk factors require identification for improved patient management.
- Understanding factors influencing contralateral tumor development is crucial for prognosis.
Purpose:
- To analyze risk factors for bilateral breast cancer in a large patient cohort.
- To differentiate between metastatic and non-metastatic bilateral breast cancer origins.
Summary:
- Advanced T stage, fixed axillary lymphadenopathy, and inflammatory signs significantly increased bilateralization risk in non-metastatic breast cancer patients.
- Histopathological features did not correlate with increased bilateralization risk.
- Two patient populations identified: those with metastatic disease and those with a longer interval between tumors, often T1 stage.
Impact:
- Identifies distinct patient groups for bilateral breast cancer, informing prognosis and follow-up strategies.
- Highlights the importance of continued clinical and mammographic surveillance for T1 tumor patients.
- Suggests that bilateral tumors in MO patients are associated with decreased survival compared to unilateral tumors.